Immunoediting of leukocyte functions within the tumor microenvironment promotes cancer metastasis development

C Dong1, G P Robertson

  • 1Department of Bioengineering, The Pennsylvania State University, University Park, PA, USA. cxd23@psu.edu

Biorheology
|September 2, 2009
PubMed

Insights

Neutrophils and IL-8 promote melanoma cell spread by increasing attachment to blood vessel walls. Targeting the V600EB-Raf pathway reduces this spread and metastasis.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Tumor cell attachment to endothelium is crucial for metastasis.
  • Neutrophils (PMN) enhance melanoma cell extravasation.
  • Interleukin-8 (IL-8) plays a role in PMN-mediated melanoma cell arrest.

Purpose of the Study:

  • To investigate the role of neutrophils and IL-8 in melanoma cell extravasation.
  • To explore the impact of targeting V600EB-Raf on melanoma cell metastasis.
  • To understand the mechanisms underlying PMN-melanoma cell adhesion.

Main Methods:

  • Studied melanoma cell attachment to endothelium under flow conditions.
  • Utilized IL-8 receptor blocking and IL-8 neutralization.
  • Assessed CD11b/CD18 up-regulation on PMN.
  • Targeted V600EB-Raf in melanoma cells (in vitro and in vivo).
  • Measured IL-8 secretion and intercellular adhesion molecule-1 (ICAM-1) expression.

Main Results:

  • Neutrophils significantly increased melanoma cell extravasation.
  • IL-8 blockade reduced PMN-mediated melanoma cell arrest and extravasation.
  • Targeting V600EB-Raf inhibited melanoma cell extravasation and lung metastasis.
  • V600EB-Raf inhibition decreased IL-8 secretion and ICAM-1 expression.

Conclusions:

  • Neutrophils and IL-8 are key players in melanoma cell metastasis.
  • Targeting V600EB-Raf offers a potential therapeutic strategy to inhibit metastasis.
  • Understanding PMN-melanoma adhesion is vital for developing anti-metastatic treatments.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...